Retracted : MicroRNA‐183 induces epithelial‐mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1
Author:
Affiliation:
1. Department of PathologyThe Third Affiliated Hospital, Guangzhou Medical UniversityGuangzhouP.R. China
2. Department of GynaecologyThe Third Affiliated Hospital, Guangzhou Medical UniversityGuangzhouP.R. China
Funder
The Health and Family Planning Commission of Guangzhou Municipality
The Scientific Research Grant from Guangdong Science and Technology Department
Publisher
Wiley
Subject
Cell Biology,Molecular Biology,Biochemistry
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.26763
Reference33 articles.
1. Endometrial cancer: A review and current management strategies: Part I
2. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
3. High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy–Treated Patients—Results from a Population-Based Breast Cancer Cohort
4. The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
5. TGF-β-induced activation of mTOR complex 2 drives epithelial–mesenchymal transition and cell invasion
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Non-coding RNAs in gynecologic cancer;Clinica Chimica Acta;2023-11
2. MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1;International Journal of Immunopathology and Pharmacology;2023-08-16
3. The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions;Frontiers in Endocrinology;2023-04-21
4. RNA-binding proteins and cancer metastasis;Seminars in Cancer Biology;2022-11
5. Human bone marrow mesenchymal stem cell-derived exosomes containing microRNA-425 promote migration, invasion and lung metastasis by down-regulating CPEB1;Regenerative Therapy;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3